Results: We find that amelioration of the arthritis occurs after treatment with rFc-μTP-L309C and results in a decrease in Th1 cells’ production of IFNγ and Th17 cells’ production of IL-17. The gene discussed is IL17A; the disease is arthritic joint disease.